GlassScriptPhysician profile
Jessica D Mcwilliams
NPI 1003549544
$1,660.61
in general payments reported to CMS, 2019-2025
17 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $283 · 2023: $116 · 2024: $998 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,297 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,297.22 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $747.96 | 2022-2025 | |
| Leo Pharma INC. | $197.77 | 2022-2024 | Adbry |
| Sun Pharmaceutical Industries INC. | $127.40 | 2024-2025 | |
| Ucb, INC. | $102.26 | 2024 | Bimzelx |
| Pfizer INC. | $98.89 | 2024 | |
| Amgen INC. | $66.99 | 2024 | Otezla |
| Galderma Laboratories, L.P. | $54.42 | 2024-2025 | Aklief |
| Incyte Corporation | $52.42 | 2024-2025 | Opzelura |
| Verrica Pharmaceuticals INC. | $50.31 | 2024-2025 | Ycanth |
| Novartis Pharmaceuticals Corporation | $27.43 | 2025 | |
| Janssen Biotech, INC. | $23.57 | 2022 | |
| Lnhc, INC | $22.97 | 2025 | Zelsuvmi |
| Regeneron Healthcare Solutions, INC. | $22.78 | 2024 | Dupixent |
| Botanix Sb INC | $18.32 | 2025 | Sofdra |
| Lilly USA, LLC | $17.56 | 2024 | Zepbound |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $15.23 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.33 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Mcwilliams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.